Indian pharma companies Cipla, Natco Pharma, Hetero Labs, and Annora Pharma have achieved a breakthrough in China after securing key bids to supply generic drugs under the country’s latest volume-based procurement (VBP) program...
Ascelia Pharma AB (publ), a biotech focused on improving the life of people living with rare cancer conditions, announced the filing of a new patent application for its first-in-class orphan liver imaging drug Orviglance
Tata 1mg, one of India’s leading e-pharmacy platforms, has entered into a strategic alliance with ClickPost, a logistics intelligence company, to enhance and automate its medicine delivery network through AI-powered Performance-Based Courier
Novo Nordisk India partners with Emcure Pharma to launch Poviztra, expanding access to semaglutide 2.4 mg for safe, effective weight loss across India.
.png)
Pfizer has clinched a major victory in the race for next-generation obesity treatments, signing a deal to acquire development-stage drugmaker Metsera Inc. after outbidding rival Novo Nordisk, the maker of Ozempic and Wegovy...
.png)
Eli Lilly’s anti-obesity drug Mounjaro has become India’s highest-selling pharmaceutical by value in October, with sales touching ?100 crore ($11.38 million). The surge reflects the growing demand for anti-obesity medications in a country...
The latest portable ultrasound device, Sonosite MT, by FUJIFILM Sonosite, is the addition to the point-of-care product range, PX, LX, and the ST. The stand provides clinicians with flexibility as the clamshell-like MT can be utilized with or...
Venus Remedies, one of the world’s top 10 manufacturers of fixed-dosage injectable drugs, has received new marketing authorizations in Vietnam for three key products methotrexate, cefuroxime, and irinotecan. These latest approvals strengthen the
Medicity, one of India’s premier super-speciality hospitals and Best Private Hospital in India, and it has unveiled its Advanced Surgical Heart Failure Clinic a state-of-the-art centre focused on the diagnosis, surgical treatment
Morgan Stanley PE-backed Omega Hospitals, based in Hyderabad, has successfully acquired Cytecare Hospitals, a prominent cancer care facility located in Bengaluru. This strategic acquisition signifies Omega's entry into a rapidly expanding
.jpg)
, CDSCO.jpg)